AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Taxation/Internal Revenue Code TAX

Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY15 Budget.

Contacted: SENATE; Labor, Dept of (DOL); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); White House Office; U.S. Agency for International Development (USAID); Health & Human Services, Dept of (HHS)

Health Issues HCR

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; H.R.1666, the Patient Centered Quality Care For Life Act, and, H.R.1339 & S.641, the Palliative Care andHospice Education and Training Act; S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.3404, the Breast Density & Mammography Reporting Act, H.R.4250 and S.2141, legislation to create a new FDA approval pathway for O.T.C. sunscreen products.

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); White House Office; State, Dept of (DOS); SENATE; Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); U.S. Agency for International Development (USAID); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Food & Drug Administration (FDA)

Bills named: H.R. 1666 (113th), H.R. 1851 (113th), S. 641 (113th), H.R. 2019 (113th), H.R. 2058 (113th), H.R. 4250 (113th), S. 1247 (113th), H.R. 1339 (113th), S. 2141 (113th), H.R. 3404 (113th), S. 1251 (113th), H.R. 460 (113th), S. 881 (113th), H.R. 2607 (113th), S. 621 (113th)

Medicare/Medicaid MMM

Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", general deficit reduction issues impacting Medicare & Medicaid, and H.R.1070, Removing Barriers to Colorectal Cancer Screening Act of 2013; H.R.2810, Medicare Patient Access & QualityImprovement Act, S.1871, the SGR Repeal & Medicare Beneficiary Access Act, and S. 2157, the Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014.

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); SENATE; White House Office; U.S. Trade Representative (USTR); Labor, Dept of (DOL); U.S. Agency for International Development (USAID); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1070 (113th), S. 1871 (113th), H.R. 2810 (113th), S. 2157 (113th)

Budget/Appropriations BUD

Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. President Obama's FY15 budget, S.1284, the FY14 Labor, Health & Human Resources Appropriations Act; H.J.Res.59, Continuing Resolution; H.R.2775,Continuing Appropriations; and H.R.3547, Omnibus Appropriations for FY14, and matters relating to the impact of the government-wide sequester as it affects CDC, NIH, NCI, Prevention & Public Health Fund, and other appropriated accounts relating to cancer.

Contacted: SENATE; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); U.S. Agency for International Development (USAID); U.S. Trade Representative (USTR); Centers For Disease Control & Prevention (CDC); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); White House Office; Labor, Dept of (DOL); State, Dept of (DOS)

Bills named: S. 1284 (113th), H.R. 2775 (113th), H.R. 3547 (113th), H.J.Res. 59 (113th)

Tobacco TOB

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and Prevention America Act, H.R.792 & S.772, cigar exemptionfrom FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY15 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership, and legislation relating to trade promotion authority.

Contacted: State, Dept of (DOS); Labor, Dept of (DOL); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); SENATE; White House Office; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR)

Bills named: S. 772 (113th), H.R. 792 (113th), S. 39 (113th), S. 194 (113th)